Literature DB >> 1977392

Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus.

Z Fronek1, L A Timmerman, C A Alper, B H Hahn, K Kalunian, B M Peterlin, H O McDevitt.   

Abstract

Susceptibility to systemic lupus erythematosus is associated with major histocompatibility complex (MHC)--encoded genes. We have used nucleotide sequence analysis to better define the disease-associated MHC alleles. HLA-DR2, DQw1, and especially the rare allele DQ beta 1. AZH confer high relative risk (RR = 14) for lupus nephritis in a Caucasian population of patients. Pilot studies using historical controls suggest that these genes also confer a high risk in non-Caucasian ethnic groups (RR = 24-78). We have found that DR4 is significantly decreased in patients with lupus nephritis. Fifty percent of the patients with lupus nephritis had either the DQ beta 1.1, the DQ beta 1.AZH, or the DQ beta 1.9 alleles. These alleles share amino acid residues that have been predicted to be the contact points for antigen and the T cell receptor. These HLA alleles appear to have a direct role in the predisposition to lupus nephritis, whereas DR4 may have a "protective" effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977392     DOI: 10.1002/art.1780331012

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Testis-/embryo-expressed genes are clustered in the mouse H-2K region.

Authors:  Y I Yeom; K Abe; D Bennett; K Artzt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

Review 3.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

Authors:  H Parsons; F Snyder; T Bowen; J Klassen; A Pinto
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?

Authors:  L M Silva; E A Donadi
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 7.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

8.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

9.  Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.

Authors:  Z Yao; A Kimura; K Hartung; P J Haas; A Volgger; G Brünnler; J Bönisch; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

Authors:  K Hartung; M P Baur; R Coldewey; M Fricke; J R Kalden; H J Lakomek; H H Peter; D Schendel; P M Schneider; S A Seuchter
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.